Shareholders that Lost Money on Merck & Co., Inc. (MRK) Should Contact Levi & Korsinsky about Pending Class Action - MRK
Portfolio Pulse from
A class action lawsuit has been filed against Merck & Co. alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion by 2030, with the stock dropping over 9% after announcing it would cease Gardasil shipments to China midyear due to lower-than-expected demand.
March 21, 2025 | 1:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck's stock price dropped over 9% following announcement of Gardasil shipment cessation in China and potential securities fraud allegations
The lawsuit alleges Merck misrepresented Gardasil sales potential in China, leading to a significant stock price decline and potential financial and reputational damage
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100